Presentation is loading. Please wait.

Presentation is loading. Please wait.

Does (HFE) hemochromatosis exist in India?

Published byTheresa McDonald Modified over 9 years ago

Similar presentations

Presentation on theme: "Does (HFE) hemochromatosis exist in India?"— Presentation transcript:

1 Does (HFE) hemochromatosis exist in India?
Rakesh Aggarwal Department of Gastroenterology SGPGI, Lucknow

2 Hemochromatosis A progressive increase in body iron content, leading to systemic iron loading of parenchymal cells (particularly hepatocytes) and, eventually, to organ disease.

3 Iron homeostasis in humans
Pietrangelo. New Engl J Med 2004; 350:

4 Hemochromatosis: Types
Primary Secondary Parenteral iron overload RBCs Iron Anemias Chronic liver disease (esp alcohol)

5 Hemochromatosis Pietrangelo. New Engl J Med 2004; 350:

6 HFE gene frequency in Caucasians
Population sample Country Sample size Prevalence of C282 homozygotes Allele frequency Electoral roll New Zealand 1,064 1 in 213 6.9% Field survey Australia 3,011 1 in 188 7.3% Primary care USA 4,865 1 in 405 5.0% Health clinic 41,038 1 in 270 6.1% USA/Canada 20,130 1 in 322 5.6% Harrison SA, Bacon BR. J Hepatol 2003; 38: S14-S23.

7 C282Y HFE mutation: Indian population
Study City Number of subjects Number of Y alleles Number of total alleles % of Y allelles Kaur, 2003 Delhi 116 *1 232 0.4 Thakur, 2004 134 268 0.0 Garewal, 2005 Chandigarh 60 120 Panigrahi, 2006 74 148 Dhillon, 2007 100 200 80 160 Agarwal, 2007 Lucknow 421 842 Jain, 2011 502 1004 Total 1 2974 0.034 * PCR using sequence-specific primers

8 HFE C282Y: Indian Thallassemics
Study City Number of subjects Number of Y alleles Number of total alleles % of Y allelles Kaur, 2003 Delhi 75 *6 150 4.0 Garewal, 2005 Chandigarh 215 430 0.0 Agarwal, 2006 Lucknow 147 294 Agarwal, 2007 308 616 Sharma, 2007 63 126 Total 6 1616 0.371 * PCR using sequence-specific primers

9 HFE C282Y: Indian liver disease patients
Study City Number of subjects Number of Y alleles Number of total alleles % of Y allelles Thakur, 2004 Delhi 249 498 0.0 Duseja, 2005** Chandigarh 16 32 Agarwal, 2006 Lucknow 65 130 Panigrahi, 2006*** 31 62 Dhillon, 2007 236 472 Jain, 2011 496 *1 992 0.1 Total 1 2186 0.046 * PCR-RFLP ** Non-alcoholic steatohepatitis *** With transferrin saturation >45%

10 H63D HFE mutation in Indian population
Study City Number of subjects Number of Y alleles Number of total alleles % of Y allelles Kaur, 2003 Delhi 116 20 232 8.6 Panigrahi, 2006 74 6 148 4.1 Dhillon, 2007 Chandigarh 100 13 200 6.5 80 160 3.8 Agarwal, 2007 Lucknow 421 47 842 5.6 Jain, 2011 502 46 1004 4.6 Total 138 2586 5.3

11 HFE H63D: Thallassemia / Liver disease
Study City Number of subjects Number of Y alleles Number of total alleles % of Y allelles Thallassemia Kaur, 2003 Delhi 75 19 150 12.7 Agarwal, 2007 Lucknow 308 49 616 8.0 Sharma, 2007 63 8 126 6.3 Total 76 892 8.5 Chronic liver disease Duseja, 2005 Chandigarh 16 4 32 12.5 Panigrahi, 2006 Delhi 31 8 62 12.9 Dhillon, 2007 236 36 472 7.6 Jain, 2011 Lucknow 496 60 992 6.0 Total 108 1558 6.9

12 Indian liver disease patients: Fe overload
Author N Findings Thakur 249 24 (9.6%) had transferrin saturation >60% Duseja 31 Only 1/23 (5%) had transferrin saturation >45%; Liver biopsy in 16: none had 3+/4+ Perl stain Dhillon 236 Only 17 (7.2%) had iron overload Jain 496 Only 13 (2.6%) had iron overload

13 Indian patients with iron overload
Shukla et al. Natl Med J India 2006; 19: 20-3.

14 Indian patients with iron overload
Shukla et al. Natl Med J India 2006; 19: 20-3.

15 Indian patients with iron overload
Shukla et al. Natl Med J India 2006; 19: 20-3.

16 Indian patients with iron overload
PCR-RFLP for C282Y Shukla et al. Natl Med J India 2006; 19: 20-3.

17 Indian patients with iron overload
HFE gene None of the 5 patients had C282Y mutation One had homozygous H63D mutation None had previously known splice site mutations Four had a IVS2+4 T/C change HAMP gene (Hepcidin) None had G71A or IVS2+1(-G) mutation SLC11A3 gene (Ferroportin) Shukla et al. Natl Med J India 2006; 19: 20-3.

18 Indian patients with iron overload
1 2 3 4 5 6 GTATGTGGAGAGGGGGC AAGG GTACGTCGAGAGGGGGC GTAYGTGGAGAGGGGGC Z Patient #1 Patient #2 Patient #3 Patient #4 Patient #5 Y = T or C Splice site Intron Exon Shukla et al. Natl Med J India 2006; 19: 20-3.

19 Other data from the Indian subcontinent
Family Origin Onset age Protein Exon AA change A Bangladesh 19 Hemojuvelin 3 C80Y B Pakistan 26 G99R C 11 D 23 P192L E 32 L194P F Sri Lanka 17 4 A343fsX23 G 21 Hepcidin 2 R42Sfs H Thailand 38 Ferroportin 7 C326Y Lok et al. Blood 2009; 114: 20-5.

20 Hemochromatosis in India: Summary
Iron overload Occasional C282Y mutation Very infrequent C282Y HFE disease Extremely rare

Download ppt "Does (HFE) hemochromatosis exist in India?"

Similar presentations

Update on Imaging: Detection of Iron in Liver and Heart Tim St. Pierre, BSc, PhD Professor School of Physics The University of Western Australia Crawley,

Update on Imaging: Detection of Iron in Liver and Heart Tim St. Pierre, BSc, PhD Professor School of Physics The University of Western Australia Crawley,
Cystic fibrosis the most common autosomal recessive (AR) disorder among Caucasians, carriers of cystic fibrosis are not affected by the disease carrier.

Cystic fibrosis the most common autosomal recessive (AR) disorder among Caucasians, carriers of cystic fibrosis are not affected by the disease carrier.
به نام یگانه هستی بخش. MODERN INSIGHTS INTO ANEMIA.

به نام یگانه هستی بخش. MODERN INSIGHTS INTO ANEMIA.
Genes and Metabolic Liver Disease: Hemochromatosis

Genes and Metabolic Liver Disease: Hemochromatosis
Hemochromatosis Jennifer Nnamdi 1414 MD4. Table of Content. Introduction Causes Signs and symptoms Diagnosis Prevention Treatment References.

Hemochromatosis Jennifer Nnamdi 1414 MD4. Table of Content. Introduction Causes Signs and symptoms Diagnosis Prevention Treatment References.
Ingested 10-20 mg/day Ingested 10-20 mg/day Absorbed 1-2 mg/day Absorbed 1-2 mg/day Lost Gut, skin, urine - 1-2 mg/day Menses - 30 mg/month Lost Gut,

Ingested mg/day Ingested mg/day Absorbed 1-2 mg/day Absorbed 1-2 mg/day Lost Gut, skin, urine mg/day Menses - 30 mg/month Lost Gut,
IRON 7 mg/1000 cal in diet; 10% absorbed Heme iron absorbed best, Fe 2+ much better than Fe 3+ –Some foods, drugs enhance and some inhibit absorption of.

IRON 7 mg/1000 cal in diet; 10% absorbed Heme iron absorbed best, Fe 2+ much better than Fe 3+ –Some foods, drugs enhance and some inhibit absorption of.
Hemochromatosis Thomas W. Faust, M.D., M.B.E.

Hemochromatosis Thomas W. Faust, M.D., M.B.E.
HEREDITARY HAEMOCHROMATOSIS. What Is It? An inherited disease characterised by excess iron deposition in various organs Leads to eventual fibrosis and.

HEREDITARY HAEMOCHROMATOSIS. What Is It? An inherited disease characterised by excess iron deposition in various organs Leads to eventual fibrosis and.
Hemochromatosis and Iron Overload Sept. 17, 2009 ICD-9-CM Coordination and Maintenance Committee Meeting.

Hemochromatosis and Iron Overload Sept. 17, 2009 ICD-9-CM Coordination and Maintenance Committee Meeting.
HEMOCHROMATOSIS Wendy Graham, MD, CCFP Academic ½ Day November 25, 2003.

HEMOCHROMATOSIS Wendy Graham, MD, CCFP Academic ½ Day November 25, 2003.
Epidemiology and Disease Pathophysiology: Hereditary Haemochromatosis

Epidemiology and Disease Pathophysiology: Hereditary Haemochromatosis
End-organ damage resulting from accumulation of iron in cells Pierre Brissot University Hospital Pontchaillou, Rennes, France.

End-organ damage resulting from accumulation of iron in cells Pierre Brissot University Hospital Pontchaillou, Rennes, France.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)

 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Prevalence of Thalassemia Major and Hepatitis C March 2013 In collaboration with Children’s Liver Foundation (Sukhbir Kaur) THINK Foundation (Vinay Shetty)

Prevalence of Thalassemia Major and Hepatitis C March 2013 In collaboration with Children’s Liver Foundation (Sukhbir Kaur) THINK Foundation (Vinay Shetty)
Contents of practice Own DNA isolation

Contents of practice Own DNA isolation
DNA diagnostics. What can we detect ? Monogenic and polygenic inherited diseases Some types of tumors Disease progress during the therapy Identification.

DNA diagnostics. What can we detect ? Monogenic and polygenic inherited diseases Some types of tumors Disease progress during the therapy Identification.
S L I D E 1 Hemochromatosis – Diagnosis and Management Pramod K. Mistry, MA, PhD, MD, FRCP Professor of Pediatrics and Medicine Chief, Pediatric Gastroenterology.

S L I D E 1 Hemochromatosis – Diagnosis and Management Pramod K. Mistry, MA, PhD, MD, FRCP Professor of Pediatrics and Medicine Chief, Pediatric Gastroenterology.
Investigating haemoglobinopathies. Carrier frequencies of thalassaemia alleles (%) Regionβ-Thalassaemiaα 0 -Thalassaemiaα + -Thalassaemia Americas 0–30–50–40.

Investigating haemoglobinopathies. Carrier frequencies of thalassaemia alleles (%) Regionβ-Thalassaemiaα 0 -Thalassaemiaα + -Thalassaemia Americas 0–30–50–40.
1. IRON METABOLISM INTRODUCTORY BACKGROUND Essential element in all living cells Transports and stores oxygen Integral part of many enzymes Usually bound.

1. IRON METABOLISM INTRODUCTORY BACKGROUND Essential element in all living cells Transports and stores oxygen Integral part of many enzymes Usually bound.

Similar presentations

Ads by Google